Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by inthno


T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Clinical Trial Size in Orphan and Rare Diseases

Note----so how many patients was the trial approved on. I would like to know...

December 4, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:Clinical Trial Size in Orphan and Rare Diseases

Hello Note and I have not attacked you in any way so not sure why this is...

December 4, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:Clinical Trial Size in Orphan and Rare Diseases

Hello Note and I have not attacked you in any way so not sure why this is...

December 4, 2023

T.ONC

RE:RE:RE:RE:RE:RE:Clinical Trial Size in Orphan and Rare Diseases

it's nice to see companies taking advantage of the AA pathway.... From...

December 4, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Clinical Trial Size in Orphan and Rare Diseases

The reason I ask is that I cannot find in the article where it states that...

December 3, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:Clinical Trial Size in Orphan and Rare Diseases

OK so that gives us hope. Can u or Norman provide a link to the trials with...

December 3, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:Clinical Trial Size in Orphan and Rare Diseases

As much as we all want AA , does anyone know of any incidence in the history...

December 3, 2023

T.ONC

RE:RE:RE:RE:RE:RE:ONCY Presented Positive GOBLET Pancreatic Cancer Data @ ESMO

Optimizing_the_Use_of_Accelerated_Approval-2020_0.pdf Ongoing | Cancer...

December 2, 2023

T.ONC

RE:RE:RE:RE:RE:ONCY Presented Positive GOBLET Pancreatic Cancer Data @ ESMO

The Seagen accelerated approval was based upon their trial with N=84 patients...

December 2, 2023

T.ONC

RE:RE:RE:ONCY Presented Positive GOBLET Pancreatic Cancer Data @ ESMO

Quick question for you notable. Accelerated approval makes sense and and...

December 2, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:Clinical Trial Size in Orphan and Rare Diseases

In  2015 ONC came out with 8 news releases announcing orphan drug status...

December 1, 2023

T.ONC

RE:RE:RE:RE:RE:Clinical Trial Size in Orphan and Rare Diseases

Hello Noteable and curious as to your thoughts as to why onc has not taken...

December 1, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:Immunogen Inc

Hello Norm and I see you are back to attacking people again as you always do....

December 1, 2023

T.ONC

RE:RE:RE:RE:Immunogen Inc

Trial size does make a different for sure and I have always wondered why they...

November 30, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:My, my.....Ithno and Ionc working overtime to trash Oncy....

Wow Angler, I was going to stop but no you had to step up and for some reason...

November 27, 2023

T.ONC

RE:RE:RE:RE:RE:My, my.....Ithno and Ionc working overtime to trash Oncy....

Angler----my only take away from all of this is that the exec never really...

November 27, 2023

T.ONC

RE:RE:RE:My, my.....Ithno and Ionc working overtime to trash Oncy....

Also Paledawn I am not trashing onc itself as I believe that they might...

November 27, 2023

T.ONC

RE:RE:My, my.....Ithno and Ionc working overtime to trash Oncy....

The information that I quoted in regards to the share ownership is directly...

November 27, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:Options

I kinda agree and disagree at the same time as I still think that a deal will...

November 26, 2023

T.ONC

RE:RE:RE:RE:RE:Options

Oh I do agree that they will all have the extra shares before expiry as there...

November 26, 2023